IPO registrations (S-1, F-1) · Registrants
PetIQ, Inc.
- SEC CIK
- 1668673 · filings on EDGAR ↗
- Registration
- Form S-1, first filed 2017-06-23, last 2017-07-20; 1 initial registration, 4 amendments
- Outcome
- Final prospectus filed 2017-07-21; declared effective 2017-07-20
- Industry (SIC)
- Wholesale-Drugs, Proprietaries & Druggists' Sundries 5122
- Incorporated in
- DE
- Business address
- PETIQ LLC, 230 E. RIVERSIDE DR., Eagle, ID 83616
- EDGAR entity type
- operating
- Insiders and CEO pay
- PetIQ, Inc. on the corporate pages
Offering terms
- Proposed price range
- $14.00–$16.00 per share (S-1/A filed 2017-07-17)
- Final price
- $16.00 per share, within the range (424B4 filed 2017-07-21, an initial public offering)
- Shares sold
- 6,250,000
- Gross proceeds
- $100,000,000 before underwriting discounts and any over-allotment option
- Listing
- Nasdaq under the symbol PETQ
- Lead underwriters
- Jefferies (2,500,000 shares)
- Syndicate
- William Blair (1,875,000); Oppenheimer (625,000); Raymond James (625,000); Truist Securities (625,000)
Read from the cover pages of the filings listed under “Prospectus pages read” below; check the document for anything that matters.
On this site
- Business registration: PETIQ, LLC Fuzzy (name and state)
- Business registration: PETIQ, LLC Fuzzy (name and state)
- SEC filer: PetIQ, Inc. EXACT (CIK (EXACT))
Filings 10
| Filed | Form | What it is | Name as filed | EDGAR |
|---|---|---|---|---|
| 2017-06-23 | S-1 | S-1 (registration) | PetIQ, Inc. | 0001193125-17-211937 ↗ |
| 2017-07-06 | S-1/A | S-1/A (amendment) | PetIQ, Inc. | 0001193125-17-223193 ↗ |
| 2017-07-11 | S-1/A | S-1/A (amendment) | PetIQ, Inc. | 0001193125-17-225835 ↗ |
| 2017-07-17 | S-1/A | S-1/A (amendment) | PetIQ, Inc. | 0001193125-17-229459 ↗ |
| 2017-07-20 | S-1/A | S-1/A (amendment) | PetIQ, Inc. | 0001193125-17-231940 ↗ |
| 2017-07-20 | S-1MEF | S-1MEF (added securities) | PetIQ, Inc. | 0001193125-17-232155 ↗ |
| 2017-07-20 | EFFECT | EFFECT (declared effective) | PetIQ, Inc. | 9999999995-17-001873 ↗ |
| 2017-07-21 | 424B4 | 424B4 (final prospectus) | PetIQ, Inc. | 0001193125-17-232942 ↗ |
| 2018-09-21 | EFFECT | EFFECT (declared effective) | PetIQ, Inc. | 9999999995-18-002435 ↗ |
| 2018-09-27 | 424B4 | 424B4 (final prospectus) | PetIQ, Inc. | 0001193125-18-285645 ↗ |
Prospectus pages read 3
| Filed | Form | Read as | Range | Price | Shares | Proceeds | Listing | Underwriters | What was found | Document |
|---|---|---|---|---|---|---|---|---|---|---|
| 2017-07-17 | S-1/A | registration statement | $14.00–$16.00 | 5,666,667 | - | Nasdaq PETQ | 5 | primary document; range, shares headline, cover names 5 | document ↗ | |
| 2017-07-20 | S-1/A | registration statement | - | - | 0 | primary document; no terms found | document ↗ | |||
| 2017-07-21 | 424B4 | final prospectus | $16.00 | 6,250,000 | $100,000,000 | Nasdaq PETQ | 5 | primary document; price table, shares headline, proceeds table, underwriting table 5, cover names 5 | document ↗ |
Officers, directors and large holders Forms 3, 4 and 5
| Insider | Role | Title | Filings | Years | On this site |
|---|---|---|---|---|---|
| Adcock Scott | Director,Officer | President | 2 | 2017 | |
| Christensen McCord | Director,Officer | Chief Executive Officer; CHIEF EXECUTIVE OFFICER | 40 | 2017–2024 | |
| Clarke James Nathan | Director | 8 | 2017–2020 | ||
| Eos Capital Partners IV, LP | TenPercentOwner | 1 | 2017 | ||
| Eos Partners, L.P. | TenPercentOwner | 4 | 2017–2021 | ||
| FIRST MARK L | Director; Director,TenPercentOwner | Non-Employee Director | 16 | 2017–2024 | |
| Kennedy Ronald | Director; Director,TenPercentOwner | Non-Employee Director | 29 | 2017–2021 | |
| MICHAEL GARY G | Director | 5 | 2017–2020 | ||
| Newland John | Officer | Chief Financial Officer | 32 | 2017–2021 | |
| Santana Will | Director; Director,Officer | Executive Vice President | 52 | 2018–2020 | |
| ECP HELIOS PARTNERS IV, L.P. | TenPercentOwner | 3 | 2018–2021 | ||
| BIRD LARRY R | Director | 13 | 2018–2021 | ||
| SHOLTIS SUSAN | Director; Officer | President; PRESIDENT | 21 | 2018–2022 | |
| Herrman Robert Michael | Officer | General Counsel; General Counsel and Secretary; GENERAL COUNSEL AND SECRETARY | 14 | 2019–2023 | |
| Smith Michael A | Officer | EVP - Products; EVP - PRODUCTS; PRESIDENT; PRESIDENT & COO | 32 | 2019–2024 | |
| Huff Scott | Director | 15 | 2019–2024 | ||
| Lefko Kimberly | Director | Non-Employee Director | 11 | 2021–2024 | |
| Oloughlin Sheryl | Director | 11 | 2021–2024 | ||
| Glasman Zvi | Officer | Chief Financial Officer; CHIEF FINANCIAL OFFICER | 8 | 2022–2024 | |
| Walker Kenneth C. | Director | 9 | 2022–2024 | ||
| Hall Allan | Director | 10 | 2022–2024 | ||
| Pearson John Paul | Officer | EVP, Services & Manufactured; EVP, SERVICES & MANUFACTURED | 6 | 2023–2024 | |
| Carter William J. | Officer | EVP, GENERAL COUNSEL | 5 | 2023–2024 | |
| Lyon Chad D. | Officer | EVP Manufacturing & Sup. Chain | 2 | 2024 |
Everyone who filed an insider report for this company, from the SEC’s Insider Transactions Data Sets (2006 on). Person pages are matched by name and state only.
Data: SEC EDGAR. The quarterly full index (every S-1, S-1/A, F-1 and F-1/A since 1993, with the pricing prospectus, notice of effectiveness and withdrawal request of each registrant) and the company submissions data (SIC, state of incorporation, address, EIN, tickers, former names). Company details are what EDGAR holds today, not at the time of the filing.
Also on this site Fuzzy
| Record | Name as filed | Where | Dataset | Matched by |
|---|---|---|---|---|
| SEC filer | PetIQ, Inc. | SEC filers (EDGAR) | CIK (EXACT) | |
| Business registration | PETIQ, LLC | State business registries | name and state | |
| Business registration | PETIQ, LLC | State business registries | name and state |
Matched by an identifier (EIN, CIK, CRD), by name and state or city, or by street address; a shared name or address is not proof of the same person or organization. Every link says how it was made; how the cross-referencing works.
Others with the same interests
SIC industry Wholesale-Drugs, Proprietaries & Druggists' Sundries, ID first:
- FV Pharma International Corp. A6
- Artemis Strategic Investment Corp AZ
- WOMEN FIRST HEALTHCARE INC CA
- China Yongxin Pharmaceuticals Inc. CA
- DAVI LUXURY BRAND GROUP, INC. CA
- Merion, Inc. CA
- FAMILYMEDS GROUP, INC. CT
- HERBALIFE LTD. E9
- CHINA MEDICINE CORP F4
- China BCT Pharmacy Group, Inc. F4
Interests: Wholesale-Drugs, Proprietaries & Druggists' Sundries